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Résumé du travail de thèse 
Introduction : Les différentes cellules endothéliales du lit vasculaire ont de nombreuses similitudes 
fonctionnelles et morphologiques. Cependant, elles présentent également une importante hétérogénéité 
structurelle et fonctionnelle qui peut avoir des implications notamment dans l'angiogenèse et le 
développement des maladies cardio-vasculaires. Peu d'études ont été publiées au sujet de l'expression et 
de la distribution des marqueurs endothéliaux dans les tissus humain normaux. 
Objectif: Nous avons étudié l'expression immunohistochimique des marqueurs endothéliaux· CD3 l, CD34, 
vWF et Fli-1 dans les vaisseaux périphériques du rein, du poumon, de la rate, du foie, du cœur et des gros 
vaisseaux; incluant l'aorte, la veine cave inférieure, l'artère rénale ainsi que les artères et veines. 
pulmonaires et fémorales. 
Matériel et méthodes : Les échantillons tissulaires ont été obtenus à partir de matériel d'autopsie et de 
biopsies. Le matériel a été fixé en formaline et inclus en paraffine. Les coupes de paraffine ont été colorées 
immunohistochimiquement avec CD31, CD34 et vWF. Les biopsies ont également été colorées 
immunohistochimiquement avec Fli-1, D2-40 et Lyve-1. 
Résultats : L'expression immunohistochimique de ces marqueurs est hétérogène dans les différents organes 
étudiés. Dans le rein, l'endothélium fenêtré des glomérules exprime fortement CD31 et CD34. Par contre, 
il n'exprime pas ou alors de manière faible et focale vWF. Dans le poumon, les capillaires alvéolaires 
expriment fortement CD3 l et CD34 mais sont habituellement négatifs pour le vWF. L'expression de vWF 
augmente graduellement avec le calibre vasculaire dans le poumon. Les sinusoïdes de la rate expriment 
CD31 de manière diffuse mais ils n'expriment pas CD34. Les sinusoïdes du foie expriment CD31 de part et 
d'autre des lobules. Par contre, CD34 est exprimé seulement dans la région périportale. L'expression de 
Fli-1 dans les cellules endothéliales est ubiquitaire et ne varie pas suivant le type de vaisseau ou d'organe. 
Fli-1 est également exprimé dans d'autres types de cellules, essentiellement des lymphocytes. D2-40 est 
exprimé seulement dans l'endothélium des vaisseaux lymphatiques. L'expression de Lyve-1 dans ce 
matériel de routine était inconstante et non reproductible. 
Conclusion : Ce.s résultats indiquent que l'expression des marqueurs endothéliaux CD31, CD34 et vWF 
est hétérogène dans le lit vasculaire et qu'elle varie entre différents vaisseaux et différents compartiments 
anatomiques du même organe. D2-40 ne marque que les cellules endothéliales lymphatiques. 
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ARTICLE 
lmmunohistochemkal Expression of Endothelial Markers 
CD31, CD34, von Willebrand Factor, and Fli-1 in Normal 
Human Tissues 
Marc P. Pusztaszeri, Walter Seelentag, and Fred T. Bosman 
lnstitute of Pathology, Lausanne, Switzerland 
su MM ARY Few systematic studies have been published comparing the expression and dis-
tribution of endothelial cell (EC) markers in different vascular beds in normal human tissues. 
We investigated by immunohistochemistry the expression of C031, C034, von Willebrand 
factor (vWF), and Fli-1 in EC of the major organs and large vessels. Tissue samples obtained 
from autopsies and biopsy specimens were routinely processed and stained immunohisto-
chemically for C031, C034, and vWF. Biopsy material was also stained immunohistochemically 
for Fli-1, 02-40, and Lyve-1. The expression pattern of the markers was heterogeneous in some 
of the organs studied. ln the kidney, fenestrated endothelium of the glomeruli strongly ex-
pressed C031 and C034 but was only focally positive or compietely negative for vWF. Alveolar 
wall capillaries of the lung strongly stained for C031 and C034 but were usually negative for 
vWF. The staining intensity for vWF increased gradually with the vessel caliber in the lung. 
Sinusoids of the spleen and liver were diffusely positive for C031. They were negative for 
C034 in the spleen and only expressed C034 in the periportal area in the liver. Fli-1 was 
expressed in all types of EC but also in lymphocytes. 02-40 stained lymphatic endothelium 
only. Lyve-1 immunostaining was too variable to be applied to routinely processed tissues. The 
expression of EC markers C031, C034, and vWF in the vascular tree is heterogeneous with 
a specific pattern for individual vessel types and different anatomie compartments of the 
same organ. 02-40 labels lymphatic EC only. (J Hîstochem Cytochem 54:385-395 2006) 
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ENDOTHELIAL CELLS (EC) have many fonctions and play a 
central role in the control of coagulation, thrombolysis, 
vascular tone, permeability, inflammation, tissue re-
pair, and angiogenesis. They constitute a heterogeneous 
cell population in the human body. Functions and, as 
a consequence, molecular characteristics of EC vary 
along the vascular tree and in the same organ between 
different vessels (Cines et al. 1998; Müller et al. 2002a). 
Few studies have been published with the intention to 
systematically compare the expression and distribution 
of EC markers in different vascular beds in normal 
human tissues in vivo. Hence, scarce data are available 
on the immunohistochemical expression pattern of com-
monly used EC markers like CD31, CD34, and von 
Willebrand factor (vWF) on normal endothelium. This is 
also the case for more recent EC markers used in vascular 
tumors, such as Fli-1, and for lymphatic endothelial 
markers such as Lyve-1 or D2-40. 
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The few studies published have mostly been re-
stricted to the lung. Müller et al. (2002a) showed that 
CD31 is usually strongly and homogeneously expressed 
by all human pulmonary EC. The expression pattern 
of CD34 and vWF was found to be more heteroge-
neous. The strongest expression of CD34 was found in 
EC of capillaries, followed by arteries, veins, arterioles, 
and venules. Two studies have been performed com-
paring the expression of vWF in human pulmonary EC 
(Kawanami et al. 2000; Müller et al. 2002b). Also in 
these studies, CD31 showed homogeneous intense 
staining in all pulmonary EC. In contrast, vWF-specific 
antibody yielded negative or weakly positive staining 
reactions in capillary EC. The staining intensity in-
creased with the vessel caliber. Veins exhibited the 
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Table 1 Antibodies used in the study 
Antibody Dilution Source Clone Incubation 
Monoclonal CD31 
Monoclonal CD34 
Polyclonal factor 8 
1/40 
1/16 
1/20 
DakoCytomation; Glostrup, Denmark 
lmmunotech; Marseilles, France 
Novocastra; Newcastle, UK 
JCJ70A Overnight 
Qbend 10 40 min 
ED15' 40 min 
Polyclonal Fli-1 (C19) 1/20 
Monoclonal 02-40 1/400 
Santa Cruz Biotechnology; Santa Cruz, CA 
Signet; Dedham, MA 
sc-356 
730-01 
40 min 
40 min 
Lyve-1 1/20 Reliatech; Braunschweig, Germany 102-PASO Overnight 
The 4-µm paraffin sections were deparaffinized in xylol 
and rehydrated in graded alcohol series. Endogenous peroxi-
dase was inhibited using 3 % H2 0 2 in methanol. The sections 
were then washed in distilled water and heated in a micro-
wave oven (in citrate buffer 10 mM, pH 6, for CD31, CD34, 
Fli-1, andLyve 1andEDTA1mM,pH7.5,for factor VIII) 15 
min for epitope retrieval. No pretreatment was needed for D2-
40. Slides were incubated first with normal horse serum (1/30 
avidin 10%) for CD31 and CD34 and with normal goat 
serum (10% avidin) for factor VIII and Fli-1 for 5 min and 
then in biotin for 10 min. Endogenous biotin was inhibited 
with a Vector Blocking kit (Vector Laboratories; Burlingame, 
CA). The slides were then incubated at 20C for 40 min with 
monoclonal antibodies for CD31, CD34, and D2-40 and 
polyclonal antibody for factor VIII and Fli-1. For CD31 and 
Lyve-1, the slides were incubated overnight at SC. The slides 
were incubated with anti-mouse/rabbit biotinylated bridging 
antibodies (dilution 1/200) for 30 min. Sections were then 
washed and incubated with standard avidin-biotin complex 
(ABC; DakoCytomation, Glostrup, Denmark) for 30 min. 
Antibody binding was revealed using H2 0 2 as a substrate and 
diaminobenzidine as chromogen. Counterstaining was per-
formed with hematoxylin. 
Results 
The expression pattern for CD31, CD34, vWF, and 
Fli-1 in the different tissues we studied was strikingly 
heterogeneous. The differences concerned especially the 
small vascular beds including continuons and fenes-
tra ted capillaries and sinusoids. Major differences 
were seen in the parenchymatous organs and are sum-
marized in Table 2. There were no significant differ-
ences between the autopsy and the biopsy tissues. 
Kidney 
The fenestrated endothelium of the glomeruli always 
strongly expressed CD31 and CD34 but was only fo-
cally positive or completely negative for vWF (Figures 
1A-1C). In one biopsy case, the glomeruli were dif-
fusely positive for vWF. In the three autopsy cases from 
hypertensive patients, the glomeruli were weakly or 
moderately positive for vWF as compared with the 
autopsy cases from patients without hypertension. 
More interstitial capillaries stained for CD34 than for 
CD31 or vWF. Fli-1 usually stained the nuclei of EC in 
the glomeruli (Figure lD), making it easier to differ-
entiate between EC and other types of cells also present 
in the glomeruli, such as podocytes or mesangial cells. 
ln addition, EC of arterioles, venules, and interstitial 
capillaries were stained. There were, however, some 
cases in which the interpretation was difficult as a result 
of important background staining. 
Lungs 
Capillaries in the alveolar wall strongly stained for 
CD31 and CD34 but were usually negative for vWF 
(Figures 2A-2C). The staining intensity for vWF also 
increased gradually with the vessel caliber. Small ar-
terioles and venules showed light staining but larger 
arteries and veins showed intense staining. The staining 
intensity did not vary according to vessel type or caliber 
for CD31 and CD34. Alveolar macrophages were posi-
tive for CD31 with a membranous pattern of staining but 
were negative for CD34 and vWF. Fli-1 diffusely stained 
the nuclei of EC of the different vessel types in the lungs 
Table 2 Staining of endothelial cells for CD31, CD34, vWF, 
and Fli-1 in various normal adult tissues 
Tissue 
Kidney 
Glomeruli 
Capillaries 
Venu les 
Arteries 
Lung 
Capillaries 
Arterioles 
Venu les 
Veins 
Arteries 
Li ver 
Periportal sinusoids 
Centrolobular sinusoids 
CD31 CD34 VWF Fli-1 (nuc/ear) 
+++ +++ 01+ 
++ +++ ++ 
+++ +++ +++ 
+++ +++ +++ 
+++ +++ 01+ 
+++ +++ ++ 
+++ +++ ++ 
+++ +++ +++ 
+++ +++ +++ 
+++ +++ ++ 
+++ 01+ ++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Centrolobular veins +++ +++ ++ +++ 
Portal venules +++ +++ ++ +++ 
Arterioles +++ +++ ++ +++ 
Spleen 
Sinusoids ++ 0 + + ++• 
Capillaries 0 +++ 01+ ++• 
Central arteries +++ +++ ++ ++• 
Venules +++ +++ ++ ++• 
Lymph nodes 
Capillaries +++ +++ ++ ++• 
Marginal sinuses +++ 01+ Of+ ++• 
High endothelial venules +++ +++ +++ ++• 
lntensity of immunohistochemical staining: 0, absent; +, low; ++, medium; 
+++, high. 
•Most cel/s present (lymphocytes) are stained. 
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Figure 1 (A) CD31 expression in the kidney showing 2 glomeruli with strong positivity. (B) CD34 expression pattern in the kidney is similar to 
CD31 but more interstitial capillaries are stained . (C) ln contrast to CD31 and CD34, the glomeruli are negative for von Willebrand factor (vWF). 
(D) Fli-1 nuclear immunostaining of EC present in the glomeruli and interstitial capillaries. 
(Figure 2D). However, the nuclei of lymphocytes were 
also stained, as well as the cytoplasm of some alveolar 
wall cells probably corresponding to mastocytes. 
Spleen 
Sinusoidal EC were diffusely positive for CD31 but 
negative for CD34 (Figures 3A and 3B). In the red pulp, 
CD34 only marked capillaries. 
vWF staining was similar to that for CD31 but 
slightly less intense (Figure 3C). There were no dif-
ferences in the staining pattern of the central arteries, 
veins, and other vessels present in the spleen. Fli-1 stained 
the nuclei of EC present in the sinusoids but also the 
lymphocytes present in the white pulp. The larger vessels 
including the central arteries also stained (Figure 3D). 
Li ver 
Sinusoïdal EC continuously expressed CD31 from the 
portal space to the centrolobular vein (Figure 4A). In 
contrast, CD34 was expressed only in the periportal 
area, the centrolobular sinusoids being mostly negative 
(Figure 4B). Expression of vWF was similar to that of 
CD31 (Figure 4C). Fli-1 usually stained the nuclei of EC 
present in the sinusoids, portal vein, centrolobular vein, 
and hepatic artery (Figure 4D). A granular cytoplasmic 
reactivity was also occasionally seen in hepatocytes. 
Heart 
The staining pattern of the intramyocardial capillaries 
was different between CD31 and CD34. More capil-
laries showed CD34 than CD31 immunoreactivity. The 
pattern of staining for vWF was similar to that for 
CD31. The endocardial endothelium strongly stained 
for CD31 but irregularly and less intensely for CD34 
and vWF. Capillaries in fat tissue were positive for 
CD34. EC from interstitial capillaries, arterioles, and 
venules present in the myocardium also stained for 
Fli-1. A diffuse cytoplasmic background staining of 
cardiomyocytes was also seen with Fli-1. 
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Figure 2 Alveolar capillaries and arterioles in the lung showing strong expression of CD31 (A) and CD34 (B). (C) ln contrast, alveolar capillaries 
are negative for vWF, whereas arterioles and venules are positive for vWF. (D) Fli-1 nuclear immunostaining of endothelial cells (EC) from 
alveolar capillaries and arterioles. 
Skin 
Small arteries, arterioles, venules, and capillaries 
present in the skin were ail stained with CD31, 
CD34, vWF, and Fli-1 in a similar fashion. Hair follicle 
cells were also occasionally positive for CD34. In the 
dermis, a reticular pattern of staining was seen with 
CD34, probably corresponding to CD34-positive mes-
enchymal cells (fibroblasts) and/or components of the 
extracellular matrix. Fli-1 also stained some lympho-
cytes present in the upper dermis and epidermis (gran-
ulation tissue). 
Bone Marrow 
Bone marrow sinuses, characterized by a discontinuons 
EC lining, were positive for CD31, CD34, and vWF. 
Capillaries, small arterioles, and venules present in the 
bone marrow in small amounts were also positive and 
did not show any significant differences for the above 
markers. Megakaryocytes were strongly positive for 
CD31 and vWF but negative for CD34. Myeloid and 
erythroid lineages cells were usually negative for the 
above markers, some cells occasionally being positive 
for CD3 l. In some cases a slight background staining 
was seen, especially with vWF. Fli-1 immunostaining in 
the bone marrow did not show nuclear staining, 
presumably due to the decalcification process. Only in 
one or two cases, the nuclei of some megakaryocytes 
and of the myeloid lineage cells were positive. 
Lymph Nodes 
Sinusoïdal EC of the marginal (subcapsular) and med-
ullary sinuses were positive for CD31 but usually nega-
tive or focally and faintly positive for CD34 and vWF 
(Figures 5A-5C). In one case, sinusoïdal EC of the 
marginal sinuses were positive for CD34 with the same 
intensity as for CD31. High endothelial venules were 
positive for CD31, CD34, and vWF. In the lymph node 
capsule, a reticular pattern of staining was also seen 
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Figure 3 (A) CD31 expression in the spleen showing positive central arteries and sinusoids with a diffuse positivity. (B) CD34 expression in the 
spleen; in contrast to CD31, sinusoids are negative but interstitial capillaries stain for CD34. (C) The expression of vWF in the spleen is similar to 
CD31, but with less staining intensity. (D) Fli-1 immunostaining in the spleen; most cells present including EC are positive. 
with CD34, probably corresponding to CD34-positive 
mesenchymal cells. Sinus histiocytes were positive for 
CD31 but negative for CD34 and vWF. Because Fli-1 
stained most lymphocytes present in the lymph node, 
evaluation of EC staining was difficult, but EC at ail 
levels seemed immunopositive for Fli-1 (Figure 5D). 
Large Vessels 
Large Arteries (Thoracic and Abdominal Aorta, 
Pulmonary Artery). The staining pattern of the endo-
thelium was similar for CD31 and CD34 in the various 
large arteries we investigated. Due to Joss of endothe-
lial cell integrity, staining of the endothelium was often 
discontinuous for CD31 and CD34. This was not the 
case with vWF, which showed a continuous pattern of 
staining with the regions depleted of EC still being 
stained for vWF. CD34 also stained some components 
of the media, probably corresponding to smooth mus-
cle cells. 
Midd/e-sized Arteries (Rena! Artery, Femoral Artery). 
Rena! arteries taken from autopsy cases showed a 
continuous and strong staining for vWF. The stain-
ing pattern was usually discontinuous for CD31 and 
CD34, the intensity being Jess for vWF. CD34 also 
stained some components of the media, probably cor-
responding to smooth muscle cells. 
Large Veins (Inferior Vena Cava, Pulmonary Vein) 
and Middle-sized Veins (Femoral Vein). The staining 
pattern of the endothelium was similar for CD31, 
CD34, and vWF for the different veins investigated. 
Lymphatic Endothelium 
In ail parenchymatous organs, small vascular spaces 
morphologically consistent with lymphatics were posi-
tive for D2-40. Such vessels were present in variable 
numbers in different organs. They were rare in the 
spleen (around central arteries and in the capsule), liver 
(in portal spaces and the capsule), kidney, and bone 
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Figure 4 (A) CD31 expression in the liver showing diffuse and continuous positivity of the sinusoids ail along the portal triad to the 
centrolobular vein. (B) CD34 expression in the li ver showing focal positivity of the sinusoids, restricted to the periportal area. (C) vWF expression 
in the liver is similar to CD31 . (D) Nuclei of EC from centrolobular vein and sinusoids are stained for Fli-1. A granular pattern of reactivity is also 
seen in the cytoplasm of hepatocytes. 
marrow. In the lungs, they were usually seen around 
veins, arterioles, and bronchioles but were very rare or 
absent in the alveolar wall. In the heart, they were 
present in small numbers in between cardiomyocytes. 
Endocardial endothelium was negative for D2-40. Sur-
prisingly, the number of D2-40-positive vessels present 
in lymph nodes was also low. The marginal and medul-
lary sinuses were negative for D2-40. In the peri-
capsular region, D2-40-positive afferent and efferent 
lymph channels could rarely be identified. Few lym-
phatic vessels were present around arteries and veins in 
the adipous tissue around lymph nodes. 
EC in arteries and veins were always negative for 
D2-40. CD31, CD34, vWF, and Fli-1 were occasionally 
and irregularly expressed in lymphatic endothelium, 
but the staining intensity was usually lower than in 
vascular endothelium and was very weak when com-
pared with D2-40. Hence, D2-40 immunostaining gives 
a mirror image when compared with the other EC 
markers (Figures 6A-6D). Mesothelial cells from the 
pleura or spleen capsule were occasionally positive for 
D2-40. This was also the case with osteocytes in the 
bone and bronchial wall chondrocytes, as well as basal 
cells from sebaceous glands and hair follicle cells, in a 
pattern similar to that of CD34. In bone marrow, he-
matopoietic stem cells including megakaryocytes were 
negative for D2-40. 
Discussion 
This study confirms that EC in different vesse! types of 
various organs express EC antigens heterogeneously. 
Variations in expression patterns were most striking in 
the small capillaries of the continuous, fenestrated, and 
sinusoid type. We could confirm studies in humans 
(Gorog et al. 1998; Yamamoto et al. 1998; Müller et al. 
2002c) and in animais (Rand et al. 1987) that show that 
the level of expression of vWF in the Jung vasculature is 
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Figure 5 (A) C031 expression in lymph nodes showing positive marginal (subcapsular) sinuses, high endothelial venu les (HEV), and capillaries. 
ln contrast, marginal sinuses are negative for C034 (B) and vWF (C). (D) Most of the ce lis present in lymph nodes including EC from capillaries 
and HEV are stained for Fli-1. 
higher in larger vessels (from being almost negligible in 
EC in alveolar capillaries but prominent in the major 
vessels). We also confirmed earlier findings in the kid-
ney concerning immunoreactivity of fenestrated endo-
thelium of the glomeruli for CD31 and CD34 but not 
for vWF and show, therefore, that antigen expres-
sion differences exist between EC in the same organ 
(Fleming and Jones 1989; Kinjo et al. 1989). We found 
that vWF expression was higher in renal glomeruli of 
patients with hypertension. This again confirms other 
studies that show upregulation of vWF expression on 
EC in hypertension and conditions such as acute respi-
ra tory failure (Carvalho et al. 1982), acute and chronic 
renal insufficiency, diabetic nephropathy (Lufkin et al. 
1979), vasculitis, scleroderma, and Raynaud's phenom-
enon (Kahaleh et al. 1981). Increased levels of circu-
lating vWF have also been described in patients with 
angina pectoris, coronary thrombotic events (Gorog 
et al. 1998), or pulmonary hypertension (Lopez and 
Maeda 1998). 
In large vessels, discontinuous immunolabeling was 
found for CD31 and CD34, in spite of continuous 
labeling for vWF. This might be explained through Joss 
of integrity of the EC lining, which was suggested by 
the presence of EC positive for CD31, CD34, and 
vWF inside the vascular lumen. Subendothelial matrix-
bound vWF could explain the continuous staining seen 
with vWF (Rand et al. 1991). Smith et al. (1996) 
showed that vWF is differentially expressed in canine 
large vessels. We were not able to confirm these find-
ings in normal human blood vessels. 
CD34 also stained some components in the media of 
large vessels. Indeed, it has been shown in earlier studies 
that aortic smooth muscle cells and some fibroblasts 
also stain for CD34 (Miettinen et al. 1994). 
We found D2-40 to be a sensitive and relatively 
specific marker for lymphatic endothelium in ail pa-
renchymatous organs. CD31, CD34, vWF, and Fli-1 
did not discriminate between vascular and lymphatic 
EC and are therefore panvascular EC markers. How-
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Figure 6 EC from arterioles and venules present in the skin are positive for C031 (A), C034 (B), and vWF (C), but negative for 02-40 (D). ln 
contrast, lymphatic EC are strongly positive for 02-40 and weakly positive for the other markers. Adipocytes and interstitial cells a round vessels 
are also positive for C034. 
ever, other cells (including mesothelial cells) also 
stained for D2-40. This is in agreement with a study 
showing that D2-40 is expressed in normal and reactive 
mcsothelial cells and in most (93-96%) mesotheliomas 
(Ordonez 2005; Ordonez in press). D2-40 is also ex-
pressed in lymphangiomas, Kaposi's sarcomas, and a 
subgroup of angiosarcomas but not in endothelial cells 
of blood vessels. To our knowledge, the fact that 
osteocytes and chondrocytes also occasionally stain for 
D2-40 has not been reported previously. We can 
hypothesize that these D2-40-positive cells might 
express sialoglycoproteins similar to those of lymphatic 
EC and with which the antibody cross-reacts. 
An important application of EC marker immuno-
histochemistry is the classification of human vascular 
tumors . CD31 is generally regarded as the single best 
marker of EC differentiation because it is expressed in 
"-'90% of EC tumors but only very rarely in carcino-
mas, lymphomas, and mesotheliomas (De Young et al. 
1998; Folpe et al. 2001). However, CD31 is also ex-
pressed in macrophages, which calls for careful inter-
preta tion of CD31 expression in poorly differentiated 
tumors (McKenney et al. 2001). CD34 is expressed in 
"-'90% of vascular tumors. It is , however, also 
expressed in many other neoplasms, including derma-
tofibrosarcoma protuberans, malignant peripheral 
nerve sheath tumors, gastrointestinal stroma! tumors, 
and epitheloid sarcomas. Notably, CD34 negative is the 
littora l cell angioma of the spleen, which correlates with 
the Jack of expression of CD34 in the sinusoids of the 
spleen (Ben-Izhak et al. 2001). Korkusuz et al. (2002) 
identified the distinctive antigenic profile of sinus lining 
cells, in sharing both endothelial ce]] and macrophage 
lineage characteristics. In embryogenesis and vasculo-
genesis, vascular and hematopoietic tissues develop 
together from the early mesoderm (Cines et al. 1998). 
Hence, it is not surprising that the antigen expression 
pattern of hematopoietic cells and EC overlap; both cell 
types express CD31, CD34, vWF, and Fli-1. A common 
stem cell has been postulated that can differentiate into 
394 
hematopoietic or vascular cells or retain characteristics 
of both, such as the littoral cells of the spleen. Like-
wise some tumors with EC stem cell-like phenotype 
or p'oorly differentiated angiosarcoma might not ex-
press ail of the commonly used EC markers (Pob~et 
et al. 1996) and/or might express some of the leukem1a/ 
lymphoma markers like CD34. . . 
Under pathological conditions, EC can mod1fy the1r 
antigen expression. In the liver, capillarization of he-
patic sinusoids is a well-recognized phenomenon th_at 
occurs in long-standing liver disease and hepatlc Clr-
rhosis as well as in hepatocellular carcinoma (HCC). 
EC of the sinusoids that usually do not express CD34 
can alter their phenotype and express this marker. On 
the contrary, Lyve-1, thought to be restricted to lym-
phatic vessels, is expressed in liver sinusoids b~t down-
regulated in liver cirrhosis and HCC (Carreira et al. 
2001). CD34 and Lyve-1 might constitute valuable 
tools to distinguish well-differentiated HCC from non-
neoplastic liver (Ruck et al. 1995; Di Carlo et al. 2002). 
Consequently, EC markers (vascular and lymphatic) 
can also aid in the diagnosis of non-vascular tumors 
and of pathological processes other than tumors. The 
usefulness of Lyve-1 as a marker for diagnostic pur-
poses is limited because the performance of the. anti-
body on routinely processed tissues was very vanable. 
We propose D2-40 for this purpose. 
For diagnostic purposes, vWF is a problematic 
marker because it is not expressed by ail EC and is 
retained in the adjacent extracellular matrix, which 
limits its reliability for identification of the presence of 
endothelial cells. In vascular tumors, it is expressed in 
only 50-75% of cases. 
In our study, Fli-1 was expressed in ail types of EC 
but was also expressed by other cell types, especially 
lymphocytes. The expression of Fli-1 did not change 
among different vesse! types or organs. This marker can 
thus be a valuable tool in diagnosing both benign and 
malignant vascular tumors, especially when used in 
conjunction with membranous EC markers such as 
CD31 or CD34. The cytoplasmic reactivity seen in he-
patocytes, renal tubular cells, and cardiomyocytes could 
be explained either by cross-reactivity with a cyto-
plasmic protein or by the presence of Fli-1 protein in the 
cytoplasm of these cells. 
In conclusion, this study confirms that EC antigen 
expression varies among different vesse! subtypes and 
different anatomie compartments of the same organ. 
The antigen expression pattern in a given organ or 
vascular bed is dynamic and can change due to a variety 
of pathological processes or simply in senescence 
(Müller et al. 2002b). Phenotypic differences of EC 
found in different vascular beds suggest highly differ-
entiated site-specific fonctions of EC. This may be the 
result of specific characteristics of EC subtypes and a 
tissue-specific microenvironment. 
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